These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5104840)

  • 21. [The quantity of antibody forming cells in the spleen and lymph nodes of Wistar rats with hormone dependent tumors].
    Iakimenko LV; Semenova-Kobzar' RA; Umanskiĭ IuA
    Biull Eksp Biol Med; 1970 Apr; 69(4):91-3. PubMed ID: 5530631
    [No Abstract]   [Full Text] [Related]  

  • 22. Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall.
    Mizushima Y; Wepsic HT; Yamamura Y; DeSilva MA; Janns G; Larson CH
    Cancer Res; 1984 Jan; 44(1):20-4. PubMed ID: 6228292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kinetics of antibody producing cells in vitro].
    Pinegin BV; Uteshev BS; Iarvelev BN; Babichev VA; Korshunov VM
    Tsitologiia; 1970 Oct; 12(10):1307-14. PubMed ID: 5535133
    [No Abstract]   [Full Text] [Related]  

  • 25. [An experimental analysis of the origin of antibody producing cells in the spleen of an intact recipient following transplantation of cells from an immunized donor].
    Fontalin LN; Pevnitskiĭ LA; Kraskina NA
    Biull Eksp Biol Med; 1967 Nov; 63(11):108-13. PubMed ID: 5634195
    [No Abstract]   [Full Text] [Related]  

  • 26. [Change in the number of antibody-producing cells in mouse spleen during carcinogenesis].
    Iakimenko LV; Umanskiĭ IuA
    Vopr Onkol; 1973; 19(7):49-52. PubMed ID: 4797963
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune responsiveness against the human placenta. I. Generation of cellular and humoral activity in experimental animals.
    Davies M; McLaughlin ME; Sutcliffe RG
    Immunology; 1982 Nov; 47(3):459-68. PubMed ID: 7129527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
    Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
    Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic potential of different lymphoid cell populations against chromium-51 labelled tumour cells.
    Pearson GR; Hodes RJ; Friberg S
    Clin Exp Immunol; 1969 Sep; 5(3):273-84. PubMed ID: 5810152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of rubomycin and carminomycin on suppressor cells participating in the regulation of the immune response].
    Vatin OE
    Antibiotiki; 1983 Apr; 28(4):307-11. PubMed ID: 6222694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-induced suppression of the in vitro humoral response.
    Lazar K; Niederhuber JE
    Surg Forum; 1975; 26():160-2. PubMed ID: 1216098
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cellular immunity and serum factors in plasmocytomas in mice].
    Lespinats G; Poupon MF; Kolb JP
    Bull Cancer; 1972; 59(4):353-62. PubMed ID: 4668253
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cancer and immunity].
    Nagel GA; Geiger C
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1605-20. PubMed ID: 4947152
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and analysis of "monofocal" antibody.
    Klinman NR
    J Immunol; 1971 May; 106(5):1345-52. PubMed ID: 5103351
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro immune response of primed mouse spleen cells as affected by the time of antigenic stimulation.
    Meiss HK; Agarossi G; Martinozzi M; Doria G
    J Cell Physiol; 1970 Aug; 76(1):3-6. PubMed ID: 5528469
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice.
    Howie S; McBride WH; James K
    Immunology; 1982 May; 46(1):43-8. PubMed ID: 7042550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular cooperation in the primary immune response. The need for a uniform terminology.
    Osoba D
    Rev Eur Etud Clin Biol; 1970 Nov; 15(9):929-33. PubMed ID: 5534061
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunodepressive properties of 5-fluorouracil in a culture of lymphoid cells].
    Uteshev BS; Pinegin BV; Babichev VA; Torchinskiĭ GA
    Dokl Akad Nauk SSSR; 1970 Feb; 190(4):969-71. PubMed ID: 5528347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.